Do aromatase inhibitors increase cardiovascular risk? Piecing together the evidence

Eur J Cancer. 2016 Nov:68:176-178. doi: 10.1016/j.ejca.2016.09.007. Epub 2016 Oct 21.

Authors

Danielle N Desautels¹, Phillip S Blanchette², Kathleen I Pritchard³

Affiliations

¹ Division of Medical Oncology, University of Toronto, Toronto, Ontario, Canada.
² Division of Medical Oncology, University of Western Ontario, London, Ontario, Canada.
³ Division of Medical Oncology, University of Toronto, Toronto, Ontario, Canada. Electronic address: Kathy.Pritchard@sunnybrook.ca.

PMID: 27776294
DOI: 10.1016/j.ejca.2016.09.007

No abstract available

Publication types

Editorial
Comment

MeSH terms

Aromatase
Aromatase Inhibitors*
Breast Neoplasms
Cardiovascular Diseases*
Enzyme Inhibitors
Humans
Risk Factors

Substances

Aromatase Inhibitors
Enzyme Inhibitors
Aromatase